BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210315
DTEND;VALUE=DATE:20210318
DTSTAMP:20260515T163042
CREATED:20201214T152316Z
LAST-MODIFIED:20201214T152538Z
UID:28302-1615766400-1616025599@www.pharmajournalist.com
SUMMARY:Targeting RNA Congress 2021
DESCRIPTION:Targeting RNA is set to be the next big thing; 85% of human genome transcribed to RNA but only 3% translated into proteins\, therefore making it an obvious target. With Risdiplam being approved by the FDA in August\, and several major collaborations also being penned throughout 2020\, including a $190 million deal between Arrakis and Roche\, it seems like a good time to target these protein precursors. \n \nThe Targeting RNA Congress will return for 2021\, March 15-17\, and will take a look at the latest techniques to analyse and predict protein structure\, as well as hearing from leading researchers and industry on how to incorporate learnings from RNA biology into potent and selective ligands to help prevent\, rather than treat\, disease. \nKey Outcomes from the summit include: \n\nLearn where to target your RNA molecules after exploring the newest biophysical techniques to analyse RNA structure\, including NMR\, Cryo-EM\, and in silico modelling with Silvi Rouskin\, (MIT)\, Wah Chiu (Stanford University) and Hashim Al Hashimi (Duke University).\nUnderstand what makes a druggable RNA target and hear from expert RNA biologists to advise how best to drug your favourite RNA targets with Anima Biotech and Craig Blain (Arrakis).\nGet translational insights into what considerations are important when creating a small molecule that targets RNA by learning how to develop tools for assessment of RNA targets with Amanda Garner (University of Michigan)\nHear what new techniques can help to drug these tricky targets\, including RNAi\, RNA degraders and RIBOTACs with Gene Yeo (UCSD)\, Jonathan Hall (Zurich) and Matt Disney (Scripps and Expansion).\n\nTo know more about Targeting RNA Congress please click here.
URL:https://www.pharmajournalist.com/event/targeting-rna-congress-2021/
LOCATION:Virtual Summit EST Timezone
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
END:VCALENDAR